Cargando…

Boost IORT in Breast Cancer: Body of Evidence

The term IORT (intraoperative radiotherapy) is currently used for various techniques that show decisive differences in dose delivery. The largest evidence for boost IORT preceding whole breast irradiation (WBI) originates from intraoperative electron treatments with single doses around 10 Gy, provid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sedlmayer, Felix, Reitsamer, Roland, Fussl, Christoph, Ziegler, Ingrid, Zehentmayr, Franz, Deutschmann, Heinz, Kopp, Peter, Fastner, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167210/ https://www.ncbi.nlm.nih.gov/pubmed/25258684 http://dx.doi.org/10.1155/2014/472516

Ejemplares similares

Intraoperative radiotherapy (IORT) as boost in breast cancer
por: Sedlmayer, Felix, et al.
Publicado: (2017)

Hsa-miR-375 is a predictor of local control in early stage breast cancer
por: Zehentmayr, Franz, et al.
Publicado: (2016)

Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid)
por: Zehentmayr, Franz, et al.
Publicado: (2015)

Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review
por: Zehentmayr, Franz, et al.
Publicado: (2020)

Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer
por: Zellinger, Barbara, et al.
Publicado: (2020)

Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
por: Fastner, Gerd, et al.
Publicado: (2022)

Correction to: IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study
por: Ciabattoni, Antonella, et al.
Publicado: (2021)

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)–a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume
por: Wurstbauer, Karl, et al.
Publicado: (2013)

Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation
por: Zehentmayr, Franz, et al.
Publicado: (2019)

Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single‐center retrospective analysis
por: Grambozov, Brane, et al.
Publicado: (2021)

DART-bid for loco-regionally advanced NSCLC: Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints
por: Wurstbauer, Karl, et al.
Publicado: (2017)

Pulmonary function decreases moderately after accelerated high‐dose irradiation for stage III non‐small cell lung cancer
por: Grambozov, Brane, et al.
Publicado: (2019)

Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis
por: Grambozov, Brane, et al.
Publicado: (2021)

miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites
por: Rinnerthaler, Gabriel, et al.
Publicado: (2016)

Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3
por: Zellinger, Barbara, et al.
Publicado: (2021)

Carbon Monoxide Diffusing Capacity (DL(CO)) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III
por: Stana, Markus, et al.
Publicado: (2022)

Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL(CO) Correlate with Radiation Dosimetry and Pneumonitis Rate
por: Stana, Markus, et al.
Publicado: (2023)

Nonmetastatic pancreatic cancer: Improved survival with chemoradiotherapy > 40 Gy after systemic treatment
por: Bachmayer, Sebastian, et al.
Publicado: (2018)

IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study
por: Ciabattoni, Antonella, et al.
Publicado: (2021)

Efficacy and Tolerance of IMRT Boost Compared to IORT Boost in Early Breast Cancer: A German Monocenter Study
por: Schumacher, Luisa, et al.
Publicado: (2022)

High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC
por: Grambozov, Brane, et al.
Publicado: (2022)

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice
por: Piroth, Marc D., et al.
Publicado: (2021)

Target splitting in radiation therapy for lung cancer: further developments and exemplary treatment plans
por: Wurstbauer, Karl, et al.
Publicado: (2009)

First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer: technical procedure
por: Roeder, Falk, et al.
Publicado: (2023)

Validation of Monte Carlo-based calculations for megavolt electron beams for IORT and FLASH-IORT
por: Lazarus, Graeme L., et al.
Publicado: (2022)

Is IORT ready for roll-out?
por: Esposito, Emanuela, et al.
Publicado: (2015)

Present state and issues in IORT Physics
por: Hensley, Frank W.
Publicado: (2017)

Intraoperative radiation therapy (IORT) in pancreatic cancer
por: Krempien, Robert, et al.
Publicado: (2017)

Biological and clinical review of IORT-induced wound fluid in breast cancer patients
por: Jeibouei, Shabnam, et al.
Publicado: (2022)

Intraoperative Radiation Therapy: A Critical Analysis of the ELIOT and TARGIT Trials. Part 1—ELIOT
por: Silverstein, Melvin J., et al.
Publicado: (2014)

Intraoperative Radiation Therapy: A Critical Analysis of the ELIOT and TARGIT Trials. Part 2—TARGIT
por: Silverstein, Melvin J., et al.
Publicado: (2014)

Comparison of IORT (Radical and Boost Dose) and EBRT in Terms of Disease-Free Survival and Overall Survival according to Demographic, Pathologic, and Biological Factors in Patients with Breast Cancer
por: Hashemi, Solmaz, et al.
Publicado: (2021)

Intraoperative radiation therapy (IORT) in soft-tissue sarcoma
por: Roeder, Falk, et al.
Publicado: (2017)

Risk-Adapted Intraoperative Radiation Therapy (IORT) for Breast Cancer: A Novel Analysis
por: Silverstein, Melvin J., et al.
Publicado: (2023)

A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer
por: Sperk, Elena, et al.
Publicado: (2014)

Recurrence and Survival Rates for 1400 Early Breast Tumors Treated with Intraoperative Radiation Therapy (IORT)
por: Silverstein, Melvin J., et al.
Publicado: (2022)

Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas
por: Nemoto, Kenji, et al.
Publicado: (2002)

End-To-End Procedure For IORT in Brain Metastases and Film Dosimetry
por: Lozares-Cordero, Sergio, et al.
Publicado: (2023)

An IGRT margin concept for pelvic lymph nodes in high-risk prostate cancer
por: Groher, M., et al.
Publicado: (2017)

Longitudinal cosmetic outcome after planned IORT boost with low kV X-rays—monocentric results from the TARGIT BQR registry
por: Goerdt, Lukas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mmb0ao0744de62uu05rs5hlvhi